With over 14 years of experience across the startup, biotech, and CRO sectors, my work focuses on translating complex innovations into clinical oncology practice. At Varian, I contributed to the foundational research and technical validation that enabled the world’s first Proton FLASH radiotherapy clinical trial. My expertise extends to the clinical implementation of adaptive radiotherapy and novel imaging solutions, such as HyperSight, alongside research into the synergistic effects of radiation and immunotherapy. Collectively, these efforts aim to advance precision oncology through the integration of high-efficiency, personalized treatment modalities.